RxDoctor Payments Data

Mohd Jibreel, MD

Hospitalist · Mesa, AZNPI 1225267156

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Johnson & Johnson at 24.5% of the total. Reporting peaked in 2019 at $1,170 and has fallen 86.1% since, to $162 in 2025. Among hospitalist clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,898in general payments, 2019–2025

Across 23 payments — averaging $82.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$466
  • Vifor Pharma, Inc.$347
  • AstraZeneca$253
  • AbbVie$219
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$216
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$162
  • plus $236 from 2 others

What the payments were for

  • Food & beverage$1,898100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,898 in reported general payments places this provider in the 95th percentile of 578 hospitalist providers in Arizona.

See all hospitalist providers in Arizona

Medicare billing

Part B allowed, 2024
$63,331
Medicare patients
263
Services billed
589

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Combivent RespimatIpratropium/Albuterol Sulfate12$5,638
Atorvastatin Calcium18$104
Pantoprazole Sodium21$103
Amlodipine Besylate17$32

Paid to pharmacies, not to this prescriber.

Other hospitalist in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →